Guardant Health

Últimas notícias

Manchetes no idioma original da fonte.

• Guardant Health Price Target Raised to $200.00/Share From $190.00 by Guggenheim (abre em uma nova aba)

  Moomoo · 1 de out. de 2026

• Guardant Health price target raised to $200 from $190 at Guggenheim (abre em uma nova aba)

  TipRanks · 1 de out. de 2026

• American Cancer Society adds Guardant Health's Shield blood test to colorectal cancer screening guideline (abre em uma nova aba)

  Florida Politics · 30 de set. de 2026

• ETFs Investing in Guardant Health, Inc. Stocks (abre em uma nova aba)

  TradingView · 30 de set. de 2026

• Total liabilities of Guardant Health, Inc. – HAN:5GH (abre em uma nova aba)

  TradingView · 30 de set. de 2026

• Could Guardant Health (NASDAQ:GH) Reset Its Market Story? (abre em uma nova aba)

  Kalkine Media · 29 de set. de 2026

• Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210 (abre em uma nova aba)

  Moomoo · 27 de set. de 2026

• Guardant Health (GH) Stock Could Be Undervalued Despite Its 5x Run (abre em uma nova aba)

  Simply Wall Street · 26 de set. de 2026

• Guardant Health co-CEO Helmy Eltoukhy on breast cancer test (abre em uma nova aba)

  CNBC · 25 de set. de 2026

• Guardant Health (GH) Rides Liquid Biopsy Growth Narrative With Valuation Still In Focus (abre em uma nova aba)

  Simply Wall Street · 25 de set. de 2026

• How FDA Approval Has Changed The Investment Story At Guardant Health Stock (abre em uma nova aba)

  Simply Wall Street · 23 de set. de 2026

• Tempus AI Fails to Trim Guardant Lawsuit Over Diagnostic Tests (abre em uma nova aba)

  Bloomberg Law News · 21 de set. de 2026

• Guardant Health (GH) Will Present 20 Abstracts At WCLC 2026 (abre em uma nova aba)

  Simply Wall Street · 19 de set. de 2026

• Insider Stock Sale Knocks Guardant Health Off Highs (abre em uma nova aba)

  TipRanks · 18 de set. de 2026

• Guardant Health Director Steve E. Krognes Sells 6,674 Shares Between $174.46 and $177.48 (abre em uma nova aba)

  Kalkine Media · 18 de set. de 2026

• Cathie Wood’s ARK increases stake in Guardant Health stock (abre em uma nova aba)

  Investing.com · 17 de set. de 2026

• Guardant Health (GH) Lands First FDA Cleared Breast Cancer Liquid Biopsy Role (abre em uma nova aba)

  Yahoo Finance · 17 de set. de 2026

• Guardant Health Insider Sold Shares Worth $1,377,364, According to a Recent SEC Filing (abre em uma nova aba)

  Yahoo Finance · 17 de set. de 2026

• Guardant Health (NASDAQ: GH) director moves to sell 6,674 shares (abre em uma nova aba)

  Stock Titan · 16 de set. de 2026

• Guardant Health (NASDAQ: GH) director may sell $144K in equity-comp stock (abre em uma nova aba)

  Stock Titan · 16 de set. de 2026

• Testing & Diagnostics Services Stocks Q2 Results: Benchmarking Guardant Health (NASDAQ:GH) (abre em uma nova aba)

  Yahoo Finance · 16 de set. de 2026

• Guardant Health at Morgan Stanley conference: shield scales, cdx gains By Investing.com (abre em uma nova aba)

  Investing.com Canada · 15 de set. de 2026

• Guardant Health stock hits 52-week high at 176.68 USD By Investing.com (abre em uma nova aba)

  Investing.com UK · 15 de set. de 2026

• Stocks Extend Losses As Market Prepares For Rate Hike: Guardant Health, Twilio, Sunoco In Focus (abre em uma nova aba)

  Investor's Business Daily · 15 de set. de 2026

• Guardant Health Director Azar Alex M II Executes 1,651 Stock Options at No Cost (NASDAQ: GH) (abre em uma nova aba)

  Kalkine Media · 15 de set. de 2026

• Patrick Dempsey Is the New Face of Guardant Health's ‘The Reckoning' Campaign (abre em uma nova aba)

  Yahoo · 15 de set. de 2026

• Piper Sandler reiterates Guardant Health stock rating on coverage outlook By Investing.com (abre em uma nova aba)

  Investing.com UK · 15 de set. de 2026

• Guardant Health rises as investors weigh recent FDA approval, coverage expansion, and supportive analyst views (abre em uma nova aba)

  Quiver Quantitative · 14 de set. de 2026

• Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening (abre em uma nova aba)

  Yahoo Finance · 14 de set. de 2026

• UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating (abre em uma nova aba)

  Yahoo Finance · 9 de set. de 2026